SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-020974
Filing Date
2021-08-23
Accepted
2021-08-23 14:55:52
Documents
51
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1173006
2 ex4-5.htm EX-4.5 60502
3 ex4-6.htm EX-4.6 63268
4 ex31-1.htm EX-31.1 20078
5 ex32-1.htm EX-32.1 9067
  Complete submission text file 0001493152-21-020974.txt   5671152

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atrx-20210630.xsd EX-101.SCH 36260
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atrx-20210630_cal.xml EX-101.CAL 32887
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atrx-20210630_def.xml EX-101.DEF 191336
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atrx-20210630_lab.xml EX-101.LAB 309625
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atrx-20210630_pre.xml EX-101.PRE 248889
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 922492
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 211196526
SIC: 2834 Pharmaceutical Preparations